PharmaCyte Biotech (PMCB) Interest Coverage Ratio Growth (1y) (2011 - 2026)
PharmaCyte Biotech (PMCB) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -25.59% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1,170.12% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 751.68% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 99.48% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -53.46% |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -89.44% |
| Apr 30, 2025 | 67.15% |
| Jan 31, 2023 | 255.42% |
| Oct 31, 2022 | -585.46% |
| Jul 31, 2022 | 32.73% |
| Jan 31, 2022 | -0.11% |
| Oct 31, 2021 | 20.88% |
| Jul 31, 2021 | -803.60% |
| Apr 30, 2021 | -139.54% |
| Apr 30, 2020 | -2,003,255.83% |
| Apr 30, 2017 | 22.85% |
| Jan 31, 2017 | 31.20% |
| Oct 31, 2016 | -171.93% |
| Jul 31, 2016 | 24.35% |
| Apr 30, 2016 | -166.52% |
| Jan 31, 2016 | -1,382.34% |
| Oct 31, 2015 | 226.27% |
| Jul 31, 2015 | -301.37% |
| Apr 30, 2015 | -41.08% |
| Jan 31, 2015 | -430.00% |